Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Asset Writedowns and Impairment (2016 - 2021)

Historic Asset Writedowns and Impairment for AtriCure (ATRC) over the last 12 years, with Q3 2021 value amounting to $82.3 million.

  • AtriCure's Asset Writedowns and Impairment changed N/A to $82.3 million in Q3 2021 from the same period last year, while for Dec 2022 it was $82.3 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $82.3 million for FY2021, which is N/A changed from last year.
  • Latest data reveals that AtriCure reported Asset Writedowns and Impairment of $82.3 million as of Q3 2021.
  • Over the past 5 years, AtriCure's Asset Writedowns and Impairment peaked at $82.3 million during Q3 2021, and registered a low of -$580000.0 during Q4 2019.
  • For the 4-year period, AtriCure's Asset Writedowns and Impairment averaged around $9.2 million, with its median value being $7000.0 (2018).
  • Per our database at Business Quant, AtriCure's Asset Writedowns and Impairment crashed by 10785.34% in 2017 and then surged by 250666.67% in 2018.
  • Quarter analysis of 4 years shows AtriCure's Asset Writedowns and Impairment stood at -$15000.0 in 2017, then surged by 2506.67% to $361000.0 in 2018, then plummeted by 260.66% to -$580000.0 in 2019, then soared by 14289.66% to $82.3 million in 2021.
  • Its Asset Writedowns and Impairment stands at $82.3 million for Q3 2021, versus -$580000.0 for Q4 2019 and $512000.0 for Q3 2019.